Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.54 |
| ▸ | F2 | P00734 | 8/20 | 0.54 |
| ▸ | F7 | P08709 | 5/20 | 0.54 |
| ▸ | PLAU | P00749 | 6/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.52 |
| ▸ | PLG | P00747 | 5/20 | 0.52 |
| ▸ | PLAT | P00750 | 5/20 | 0.52 |
| ▸ | F9 | P00740 | 4/20 | 0.49 |
| ▸ | F11 | P03951 | 3/20 | 0.49 |
| ▸ | HPN | P05981 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29639097 | 0.90 | F10 (0.65) | F10F2F7PLAUPRSS1 | |
| SCHEMBL7399288 | 0.81 | F10 (0.55) | F10F2F7PLAUPRSS1 | |
| SCHEMBL23793430 | 0.81 | F10 (0.52) | F10F2F7PLAUPRSS1 | |
| SCHEMBL7409967 | 0.80 | F10 (0.60) | F10F2F7PLAUPRSS1 | |
| SCHEMBL7403427 | 0.80 | F10 (0.60) | F10F2F7PLAUPRSS1 | |
| Hydrochloric Acid SCHEMBL28582597 | 0.80 | F10 (0.51) | F10F2F7PLAUPRSS1 | |
| Hydrochloric Acid SCHEMBL30386854 | 0.80 | F10 (0.51) | F10F2F7PLAUPRSS1 | |
| SCHEMBL23793907 | 0.79 | F2 (0.83) | F10F2F7PLAUPRSS1 | |
| SCHEMBL147654 | 0.79 | KDM4E (0.60) | — | |
| SCHEMBL30860691 | 0.79 | KDM4E (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0943008-B1 | METAL MEDIATED SERINE PROTEASE INHIBITORS | AXYS PHARM INC (US) | 2005-11-09 | — | — | EP | disclosed |
| US-6355460-B1 | DETECTING ENZYME INHIBITORS; INCUBATE ENZYME WITH MODULATOR, MONITOR SAMPLE FOR REDUCTION IN ENZYME ACTIVITY, REDUCTION IN ENZYME ACTIVITY INDICATES MODULATOR | AXYS PHARMACEUTICALS, INC. | 2002-03-12 | — | — | US | disclosed |
| US-6255091-B1 | ASSAYING FOR ENHANCED INHIBITION OF SERINE PROTEASE IN A MEDIUM THAT IS DEVOID OF DISSACIATED DIVALENT METAL CATIONS | AXYS PHARMACEUTICALS, INC. | 2001-07-03 | — | — | US | disclosed |
| US-6150379-A | BLOOD COAGULATION FACTOR XA INHIBITORS; TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE ACTIVITY; THROMBOLYTIC AND ISCHEMIC AGENTS; E.G., 2-(6-(5-AMIDINO-1H-BENZIMIDAZOL-2-YL)-PYRID-3-YLCARBONYLAMINO)-3 -HYDROXYBUTYRIC ACID | AXYS PHARMACEUTICALS, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| EP-0943008-A1 | METAL MEDIATED SERINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1999026941-A1 | SUBSTITUTED AMIDINOARYL DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | AXYS PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1998022619-A1 | METAL MEDIATED SERINE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-05-28 | — | — | WO | disclosed |